Skip to main content

Statin Therapy at Discharge after Lower Extremity Bypass (LEB)

CBE ID
1519
Endorsement Status
E&M Committee Rationale/Justification

Steward no longer seeking to maintain endorsement

1.0 New or Maintenance
1.1 Measure Structure
Previous Endorsement Cycle
Is Under Review
No
1.6 Measure Description

Percentage of patients aged 18 years and older undergoing infrainguinal lower extremity bypass who are prescribed a statin medication at discharge. This measure is proposed for both hospitals and individual providers.

    Measure Specs
      General Information
      1.7 Measure Type
      1.3 Electronic Clinical Quality Measure (eCQM)
      1.14 Numerator

      Patients undergoing infrainguinal lower extremity bypass who are prescribed a statin medication at discharge.

      1.15 Denominator

      All patients aged 18 years and older undergoing lower extremity bypass as defined above who are discharged alive, excluding those patients who are intolerant to statins.

      Exclusions

      Chart documentation that patient was not an eligible candidate for statin therapy due to known drug intolerance, or patient died before discharge.

      Most Recent Endorsement Activity
      Endorsed Surgery Project 2015-2017
      Initial Endorsement
      Last Updated
      Removal Date
      Steward Organization
      Society for Vascular Surgery
      Steward POC email
      SMurphy@vascularsociety.org
                Public Comments